{"id":"W2949315927","doi":"10.1097/01.hs9.0000563256.18006.bf","title":"PS1244 REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF PATIENTS DIAGNOSED WITH CLASSICAL HODGKIN LYMPHOMA (CHL) TREATED WITH ANTI‐PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Pediatrics; Internal medicine; Retrospective cohort study; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000571396,0.0002024154,0.0002936597,0.00171934,0.0002866775,0.0006788307,0.0004123544,0.000364218,0.002091652],"category_scores_gemma":[0.002026704,0.0002507824,0.0005276072,0.003517811,0.0002052011,0.0006170751,0.0005925086,0.0006030429,0.0003265662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007906412,"about_ca_system_score_gemma":0.0007388716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0185938,"about_ca_topic_score_gemma":0.01805502,"domain_scores_codex":[0.999218,0.000186205,0.0001804879,0.0001810273,0.0001330581,0.0001012949],"domain_scores_gemma":[0.9969079,0.0003355751,0.002172379,0.0001101777,0.0001900725,0.0002839287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005844189,0.00002049544,0.9981439,0.00002431847,0.00007416202,0.00002719122,0.0000274422,0.0000933611,0.00003031789,0.00002190539,0.0007372478,0.0007412441],"study_design_scores_gemma":[0.000008977523,0.00004789714,0.9984375,0.00002553208,0.00002920651,0.0001534762,0.0001747732,0.0004270198,0.00003267759,0.00002295637,0.0006350647,0.000004994838],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.970744,0.00074214,0.0001173872,0.0001642627,0.00001535199,0.00003157238,0.02713284,0.00001633872,0.001036009],"genre_scores_gemma":[0.9891968,0.0003123369,0.0001094278,0.00009074288,0.00002039591,0.0000495461,0.01006435,0.00000452728,0.0001517583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0185938,"threshold_uncertainty_score":0.03697109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01748511497946377,"score_gpt":0.2568747551991565,"score_spread":0.2393896402196928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}